The cancer researcher and executive vice president of AstraZeneca’s oncology research and development is well known for his role in the development of pivotal breast cancer therapies.

The oncologist developed lifesaving childhood leukemia treatments and revolutionized chemotherapy.

Better understanding the CD8+ T cells already present in tumors could be key to making immunotherapies work for more patients.

Strategies to trick, manipulate, and direct the evolution of tumors

The Vanderbilt University professor was awarded a Nobel Prize for his discovery of epidermal growth factor.

Colorectal tumor cells limit their DNA repair in response to a targeted therapy, giving them a greater chance to develop resistance to the drug.

A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.

Fly avatars bearing multiple genetic changes akin to those of a cancer patient lead to a tailor-made treatment that has shrunk the patient’s tumors.

The scientist and clinician helped develop a new form of cancer therapy, using a monoclonal antibody to treat head, neck, colorectal, and lung cancers.